China Biologic Products - 48 Year Dividend History | CBPO

Historical dividend payout and yield for China Biologic Products (CBPO) since 1971. The current TTM dividend payout for China Biologic Products (CBPO) as of July 15, 2019 is $0.00. The current dividend yield for China Biologic Products as of July 15, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.677B $0.467B
China Biologic Products, Inc., through its indirect majority-owned subsidiary, is principally engaged in the research, development, production, manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Its subsidiary, Shandong Taibang Biological Products Co. Ltd., operates from its manufacturing facility located in Taian City, Shandong Province. The Company's principal products include its approved human albumin and immunoglobulin products. These human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $106.696B 12.06
Gilead Sciences (GILD) United States $84.475B 10.26
CSL Sponsored ADR (CSLLY) Australia $34.985B 0.00
Bio-Techne Corp (TECH) United States $7.927B 54.08